A Biomimetic Dual‐Targeting Nano‐APA‐Editor Reprograms the 3'UTR Landscape for Tongue Squamous Cell Carcinoma Therapy
Advanced Science · 2026
DOI: 10.1002/advs.76126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yiran Ao und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Hubei Key Laboratory of Stomatology, Key Laboratory of Oral Biomedicine…. Hauptthemen laut MEDLINE: 3' Untranslated Regions, Biomimetics, Tongue Neoplasms, Cleavage And Polyadenylation Specificity Factor. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Targeting post‐transcriptional dysregulation of tumor suppressors represents a new frontier in cancer therapy. Here, we identify the alternative polyadenylation (APA) regulator NUDT21 as a pivotal therapeutic target in oral squamous cell carcinoma (OSCC). NUDT21 is highly upregulated, correlating strongly with poor survival and advanced clinical stage. We outline a pathogenic mechanism whereby NUDT21 drives this phenotype by forcing a network of tumor suppressor transcripts, notably PTEN, into translationally‐repressed, long‐3'UTR isoforms. To therapeutically “re‐engineer” this APA switch, we design a “Nano‐APA‐editor.” This platform features an HMSN core with an sgRNA‐NUDT21 payload and a hierarchical targeting strategy: a cancer‐educated dendritic cell (DC) membrane for biomimetic camouflage and homotypic affinity, “gated” by a TA‐aptamer for final precision. This system enables potent and selective NUDT21 silencing, driving a shift toward short‐3'UTR isoforms. Consequently, the Nano‐APA‐editor effectively reinstates PTEN and associated suppressors and inhibits multiple malignant phenotypes in vitro. In an orthotopic OSCC model, it demonstrates profound tumor regression, outperforming conventional chemotherapy (PTX) with excellent biocompatibility. In vivo analysis confirmed target engagement (NUDT21‐down) and functional restoration (PTEN‐, WEE1‐, TGF‐β‐up). This work validates a “post‐transcriptional re‐engineering” strategy, executed by a logically designed nanoplatform, as a powerful and safe modality for precision gene therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Hubei Key Laboratory of Stomatology, Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan Univer…
- Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, P. R. China.
ORCID-Profile: Qin Zhao
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Ao, Y., Gu, B., Zhao, H., Tan, K., Zhao, Q., & Shang, Z. (2026). A Biomimetic Dual‐Targeting Nano‐APA‐Editor Reprograms the 3'UTR Landscape for Tongue Squamous Cell Carcinoma Therapy. Advanced Science. https://doi.org/10.1002/advs.76126
Vancouver
Ao Y, Gu B, Zhao H, Tan K, Zhao Q, Shang Z. A Biomimetic Dual‐Targeting Nano‐APA‐Editor Reprograms the 3'UTR Landscape for Tongue Squamous Cell Carcinoma Therapy. Advanced Science. 2026. doi:10.1002/advs.76126
BibTeX
@article{Ao2026,
author = {Ao, Yiran and Gu, Bin and Zhao, Hui and Tan, Kun and Zhao, Qin and Shang, Zhengjun},
title = {A Biomimetic Dual‐Targeting Nano‐APA‐Editor Reprograms the 3'UTR Landscape for Tongue Squamous Cell Carcinoma Therapy},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76126}
}
EUVIMED